| Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis G Niu, KL Wright, M Huang, L Song, E Haura, J Turkson, S Zhang, ... Oncogene 21 (13), 2000-2008, 2002 | 1597 | 2002 |
| Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells T Wang, G Niu, M Kortylewski, L Burdelya, K Shain, S Zhang, ... Nature medicine 10 (1), 48-54, 2004 | 1439 | 2004 |
| The orderly progression of melanoma nodal metastases D Reintgen, CW Cruse, K Wells, C Berman, N Fenske, F Glass, K Schroer, ... Annals of surgery 220 (6), 759-767, 1994 | 914 | 1994 |
| Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma AI Daud, RC DeConti, S Andrews, P Urbas, AI Riker, VK Sondak, ... Journal of clinical oncology 26 (36), 5896, 2008 | 844 | 2008 |
| Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy LM Mir, LF Glass, G Serša, J Teissie, C Domenge, D Miklavčič, ... British journal of cancer 77 (12), 2336-2342, 1998 | 587 | 1998 |
| In vivo gene electroinjection and expression in rat liver R Heller, M Jaroszeski, A Atkin, D Moradpour, R Gilbert, J Wands, ... FEBS letters 389 (3), 225-228, 1996 | 551 | 1996 |
| Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo G Niu, R Heller, R Catlett-Falcone, D Coppola, M Jaroszeski, W Dalton, ... Cancer research 59 (20), 5059-5063, 1999 | 470 | 1999 |
| Theory and in vivo application of electroporative gene delivery S Somiari, J Glasspool-Malone, JJ Drabick, RA Gilbert, R Heller, ... Molecular Therapy 2 (3), 178-187, 2000 | 405 | 2000 |
| Electrochemotherapy: from the drawing board into medical practice D Miklavčič, B Mali, B Kos, R Heller, G Serša Biomedical engineering online 13, 1-20, 2014 | 382 | 2014 |
| Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy R Heller, MJ Jaroszeski, LF Glass, JL Messina, DP Rapaport, RC DeConti, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 378 | 1996 |
| Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin R Heller, MJ Jaroszeski, DS Reintgen, CA Puleo, RC DeConti, RA Gilbert, ... Cancer 83 (1), 148-157, 1998 | 344 | 1998 |
| Needle electrodes for mediated delivery of drugs and genes GA Hofmann, RA Gilbert, Y Hayakawa, R Heller, MJ Jaroszeski US Patent 5,702,359, 1997 | 318 | 1997 |
| Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma X Wang, R Heller, N VanVoorhis, CW Cruse, F Glass, N Fenske, ... Annals of surgery 220 (6), 768-774, 1994 | 315 | 1994 |
| IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16. F10 melanoma ML Lucas, L Heller, D Coppola, R Heller Molecular Therapy 5 (6), 668-675, 2002 | 309 | 2002 |
| In Vivo Electroporation for Gene Therapy LC Heller, R Heller Human gene therapy 17 (9), 890-897, 2006 | 279 | 2006 |
| Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments AM Bodles-Brakhop, R Heller, R Draghia-Akli Molecular Therapy 17 (4), 585-592, 2009 | 278 | 2009 |
| Transfection by electroporation H Potter, R Heller Current protocols in molecular biology 121 (1), 9.3. 1-9.3. 13, 2018 | 267 | 2018 |
| Clinical applications of electrochemotherapy R Heller, R Gilbert, MJ Jaroszeski Advanced drug delivery reviews 35 (1), 119-129, 1999 | 261 | 1999 |
| Novel electrode designs for electrochemotherapy RA Gilbert, MJ Jaroszeski, R Heller Biochimica et Biophysica Acta (BBA)-General Subjects 1334 (1), 9-14, 1997 | 220 | 1997 |
| Electroporation gene therapy preclinical and clinical trials for melanoma L C Heller, R Heller Current gene therapy 10 (4), 312-317, 2010 | 218 | 2010 |
